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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe RNA-binding protein L1TD1 is one of themost specific and abundant proteins in pluripotent stem cells and is essential for themain-
tenance of pluripotency in human cells. Here, we identify the protein interaction network of L1TD1 in human embryonic stem cells
(hESCs) and provide insights into the interactome network constructed in human pluripotent cells. Our data reveal that L1TD1 has
an important role in RNA splicing, translation, protein traffic, and degradation. L1TD1 interacts withmultiple stem-cell-specific proteins,
many of which are still uncharacterized in the context of development. Further, we show that L1TD1 is a part of the pluripotency inter-
actome network of OCT4, SOX2, and NANOG, bridging nuclear and cytoplasmic regulation and highlighting the importance of RNA
biology in pluripotency.INTRODUCTION
Pluripotent human embryonic stem cells (hESCs) can
differentiate into all somatic cells of the human body and
hold tremendous potential for developmental biology,
drug screening, and regenerative medicine (Thomson
et al., 1998). The importance of the core pluripotency tran-
scription factors OCT4, NANOG, and SOX2 in the mainte-
nance and induction of pluripotency has been well
documented (Boyer et al., 2005; Takahashi and Yamanaka,
2006; Yu et al., 2007). However, a variety of post-transcrip-
tional processes control and alter the original message after
transcription. In addition, protein degradation by protea-
somes has been suggested to have a vital role maintaining
pluripotency (Buckley et al., 2012; Vilchez et al., 2012).
The role of post-transcriptional regulators and protein net-
works in the maintenance of pluripotency is still largely
unknown, especially in human cells.
L1TD1 is highly and specifically expressed in pluripotent
cells (Iwabuchi et al., 2011; Mitsui et al., 2003; Na¨rva¨ et al.,
2012; Wong et al., 2011) under the control of OCT4,
NANOG, and SOX2 (Boyer et al., 2005; Na¨rva¨ et al., 2012;
Wong et al., 2011). We previously reported that L1TD1 is
essential for maintaining the pluripotent state in hESCs
(Na¨rva¨ et al., 2012). Like LIN28, which is one of the well-
characterized post-translational regulators of pluripotency
(Huang, 2012), L1TD1 is an RNA-binding protein (RBP).
RBPs have a fundamental role in a wide variety of cellular
processes, including RNA transcription, splicing, process-
ing, localization, stability, and translation. Moreover,Stem Ceach RBP has unique and specific roles (Glisovic et al.,
2008). Given its highly specific expression and vitality in
pluripotent cells, we expect that L1TD1 regulates themain-
tenance of the pluripotent state.
Transcriptomic studies have provided a large amount of
data concerning genes that are specifically expressed in
the pluripotent state. However, this information can only
be used to predict the behavior of proteins that are impor-
tant for themaintenance of pluripotency. Combinations of
mass spectrometry (MS) and bioinformatics studies have
increased our understanding of the proteins and pathways
that are active in ESCs (Jadaliha et al., 2012; VanHoof et al.,
2006, 2009). Only recently, affinity purifications combined
withMS have shed light on the protein-protein interaction
networks of individual pluripotency factors and themolec-
ular networks that regulate pluripotency. The interactome
for Oct4, Sox2, and Nanog, along with other individual
transcription factors, has been reported in mouse ESCs
(mESCs) (Ding et al., 2012; Gao et al., 2012; Liang et al.,
2008; Pardo et al., 2010; van den Berg et al., 2010; Wang
et al., 2006). However, the functional protein-protein inter-
actions in hESCs have remained unexplored. Notably, the
protein networks that are distinct from transcriptional-
control networks in pluripotent cells remain unknown.
To elucidate interacting and functional components
involved in the regulation of humanpluripotency, we char-
acterized proteins associated with L1TD1. Furthermore, we
validated selected interactions in hESCs and human
induced pluripotent stem cells (hiPSCs). We show that
the pluripotency network of L1TD1 is shared with theell Reports j Vol. 4 j 519–528 j March 10, 2015 j ª2015 The Authors 519
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OCT4, NANOG, and SOX2 interactomes, and contains
uncharacterized protein players that are important for
maintenance of pluripotency. Our data significantly
expand the current knowledge about the biology of RBPs
and provide an important resource of protein interactions
in human pluripotent cells.RESULTS
L1TD1 Interactome
The biological function of a protein is determined by its
structure. L1TD1 consists of a C-terminal coiled coil (CC)
domain, an RNA recognition motif (RRM) domain, a C-ter-
minal carboxyl tail domain (CTD) domain, and anN-termi-
nal CTD domain (Figure 1A). The N-terminal RRM domain
is exceptional in that only 30 of its C-terminal amino acids
(K216–D248) are typical of RRM domains. This ‘‘unique
sequence’’ possibly contains the CC domain and the rest
of the RRM domain, but it clearly differs from the se-
quences found in typical CC and RRM domains. Based on
these structural domains, we conclude that L1TD1 is an
RBP. However, the middle region of L1TD1 contains an
exceptional poly-E repeat region. Interestingly, nucleolin,
whose structure has an unusual combination of Poly-E
and RRM domains, has been shown to specifically recruit
proteins that are important for its unique function, with
the help of the acidic poly-E region (Edwards et al., 2000;
Erard et al., 1988; Lapeyre et al., 1987). On the basis of these
similarities, we speculated that by determining the proteins
that interact with L1TD1, we could identify protein
complexes that are important for the maintenance of
pluripotency.
To identify the L1TD1 protein network and to exclude
secondary partners interacting through RNA, we carried
out immunoprecipitation (IP) in the presence of RNase
with two specific anti-L1TD1 antibodies (Figure S1) that
recognize distinct regions of the L1TD1 protein (Figure 1A).Figure 1. L1TD1-Interacting Proteins Are Involved in RNA Proces
(A) Schematic diagram of the human L1TD1 protein structure: coiled c
tail domain (CTD). Regions targeted by antibodies 1 and 2 used in the
(2011).
(B) Venn diagram of the proteins identified in the L1TD1 interactome
(C) Clusters of the most enriched biological processes in the L1TD1 in
et al., 2011) were visualized using Cytoscape 2.8.1 (Shannon et al., 2
(D) The three most significant functions of L1TD1 interactome prote
experimentally are shown in red.
(E) Western blot (WB) validations of individual protein-protein inter
negative control. hESC line HS360. CTNNB1 separate IP reaction, DDX
(F) Protein expression of the interacting proteins after L1TD1 silencing
in the Supplemental Results.
See also Figure S1 and Tables S1, S2, and S3.
Stem CThe availability of highly specific antibodies against L1TD1
enabled IP of the endogenous protein, excluding possible
overexpression effects. The strategy used to overexpress
tagged fusion protein was unsuccessful, as the overex-
pressed fusion protein of L1TD1 was rapidly cleaved in
living cells (data not shown). Liquid chromatography-tan-
dem MS (LC-MS/MS) analysis of three biological replicates
resulted in the detection of 306 proteins putatively
belonging to the L1TD1 interactome (Figure 1B; Table
S1). Immunoglobulin G (IgG) control IPs were used as a
negative control. In addition, we carried out a CRAPome
analysis (Mellacheruvu et al., 2013) to identify the speci-
ficity of the interactions (Table S2).
In order to identify biological processes through which
L1TD1mediates its function, we analyzed the L1TD1 inter-
actome with several of the currently available Gene
Ontology and interaction analysis tools. First, we investi-
gated known interactions within the L1TD1 interactome
based on the STRING interaction database (Szklarczyk
et al., 2011). This revealed highly connected components
of proteins involved in RNA-processing biology. In partic-
ular, RNA translation (21.6%) and splicing (10%) were
identified as key functions (Figure 1C; Table S3). Among
the other notable associated functions were intracellular
transport (9.6%), protein folding (5.6%), and the proteoso-
mal ubiquitin-dependent protein catabolic process (3%).
Ingenuity Pathway Analysis (IPA) further confirmed that
the top three functions of L1TD1-interacting proteins
were gene expression, post-transcriptional modification,
and protein synthesis (Figure 1D). Collectively, these re-
sults suggest that L1TD1 is involved in multiple steps
ranging from RNA production to the production of a func-
tional protein.
To establish the validity of the detected interaction
network, we confirmed randomly selected individual inter-
actions with specific antibodies (Figure 1E). In addition,
silencing of L1TD1 resulted in reduced expression of
most of the interacting partners (Figure 1F). Taken togethersing
oil (CC) domain, RNA recognition motif (RRM) domain, and carboxyl
IPs are shown. Protein domain borders are based on Khazina et al.
(shaded area) based on MS analysis of three biological replicates.
teractome. Data from the STRING interaction database (Szklarczyk
003).
ins based on Ingenuity Pathway Analysis (IPA). Proteins validated
actions in L1TD1, IgG control, and unbound (UB) IP reactions. NC,
3X and PABPC1 separate IP reaction, hESC line H9.
. NT, non-targeting. hESC line HS360. Quantifications can be found
ell Reports j Vol. 4 j 519–528 j March 10, 2015 j ª2015 The Authors 521
Figure 2. The L1TD1 Interactome Uncovers the Importance of RBPs and the Potential Role of L1TD1 in Nuclear Pore Traffic
(A) RBPs that were both identified here in the L1TD1 interactome in hESCs and previously reported in mESCs (Kwon et al., 2013). Proteins
were grouped according to the CRAPome percentages (Workflow 1). Proteins with 0.8-1 SAINT probability are shown in bold (Workflow 3).
(B) WB validation of SRSF3 and U2AF1 interactions in L1TD1, IgG control, and UB IP reactions. hIPSC line HEL 11.4.
(C) Subcellular location of L1TD1-interacting proteins based on IPA software.
(legend continued on next page)
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with the previous observation that the silencing of L1TD1
has a rapid effect on pluripotency (Na¨rva¨ et al., 2012), our
results suggest that interacting proteins that respond to
L1TD1 silencing participate in the maintenance of plurip-
otency along with L1TD1.
L1TD1 Interacts with Multiple RBPs
To gain further insight into the network revealed by these
measurements, we classified the L1TD1 interactome on
the basis of the structural domains of the interaction part-
ners (Table S4). Based on this, 58 proteins (19%) were clas-
sified as ribosomal proteins, providing further evidence
that L1TD1 is involved in translation. Interestingly,
another major class (10%, 31 proteins) identified was pro-
teins with the RNA-binding domain RRM or KH (K homol-
ogy), suggesting that L1TD1 performs its function in a
complex with other RBPs.
Recently, Kwon et al. (2013) reported an RNA-binding
repertoire of mESCs including 283 RBPs. A comparison of
these RBPs with the L1TD1 interactome resulted in the
identification of 89 shared RBPs, 72 of which had high
significance based on the CRAPome (Figure 2A). Based on
this comparison, 29% of the L1TD1-interacting proteins
bind RNA. Moreover, two RBPs that interact with L1TD1,
U2af1, and Srsf3 (Figure 2B) were recently shown to be
vital for somatic cell reprogramming in mESCs (Ohta
et al., 2013).
L1TD1 Traffics between the Nucleus and Cytoplasm
Most of the L1TD1-interacting proteins identified were
annotated as cytoplasmic in location (Figure 2C), although
more than 30% were nuclear proteins. The presence of nu-
clear proteins in the L1TD1 interactome led us to reanalyze
the cellular location of L1TD1. In a previous study,we local-
ized L1TD1 in the cytoplasmic processing bodies (P-bodies)
based on its co-location with AGO2 and LIN28 (Na¨rva¨
et al., 2012). However, both of these proteins are able to
traffic between the cytoplasm and nucleus (Balzer and
Moss, 2007; Robb et al., 2005). In addition, a recent MS
analysis identified L1TD1 in the nuclear fraction (Sarkar
et al., 2012). To test whether L1TD1 is found in the nucleus,
we carried out cell fractionation experiments. The results
showed the presence of L1TD1 and LIN28 in both the nu-
clear and cytoplasmic fractions, whereas OCT4, NANOG,(D) Expression of L1TD1, KPNA2, LIN28, OCT4, NANOG, SOX2, GAPDH
cytoplasmic (C), and nuclear (N) cell fractions of hESCs (H9), 2102EP
(E) Immunostaining of L1TD1 (red), DNA (DAPI staining, blue), NANO
(F) WB validation of KPNA2, L1TD1, and RAE1 interactions in L1TD1, K
the experiment shown in Figure 1E. KPNA2 IP hIPSC line HEL24.3.
(G) Effect of L1TD1 silencing on the expression of KPNA2 and OCT4. h
Results.
See also Table S2.
Stem Cand SOX2 showed extensive nuclear expression (Fig-
ure 2D). The location was also validated in cancer cell lines
expressing endogenous L1TD1 (Figure 2D).
Based on the immunostainings, we concluded that most
of the L1TD1 complexes localize adjacent to the nuclear
membrane (Figure 2E). This led us to analyze the L1TD1 in-
teractome for the presence of possible binding partners
associated with the nuclear membrane and nuclear pore
traffic. In addition to identifyingmultipleproteins involved
in cellular transport, we identified key factors in nuclear
pore traffic, such as KPNA2, RAN, and RAE1. Interestingly,
karyopherin KPNA2 is enriched in undifferentiated ESCs
(Van Hoof et al., 2006) and has been shown to be respon-
sible for the nuclear import of OCT4 (Young et al., 2011).
Furthermore, RAE1 is a componentof thenuclear pore com-
plex involved in RNA export (Murphy et al., 1996). We
validated the cytoplasmic and nuclear location of KPNA2
(Figure 2D), as well as interactions of KPNA2 and RAE1
with L1TD1 (Figure 2F). Further, by reciprocal pull-down
of KPNA2, we were able to validate the interaction with
L1TD1 andOCT4 (Figure 2F). In addition,we demonstrated
that silencing of L1TD1 results in decreased KPNA2 and
OCT4 levels (Figure 2G). These findings strongly suggest
that L1TD1 is able to traffic between the nucleus and cyto-
plasm and participate in nuclear pore traffic.
L1TD1 Levels Are Rapidly Decreased by Proteasome
Inhibitor
The LC-MS/MS analysis resulted in the identification of
multiplemembers of the ubiquitin-dependent proteasome,
such as PSMD1, PSMD2, PSMD7, PSMD8, PSMD11, and
PSMD14. Of particular interest, PSMD11 was recently re-
ported to be responsible for the increased proteasome activ-
ity in hESCs, which is important for the maintenance of
pluripotency (Vilchez et al., 2012). The interaction be-
tween L1TD1 and PSMD11 was validated with immuno-
blotting (Figure 3A). Moreover, silencing of L1TD1 resulted
in decreased levels of PSMD11 (Figure 3B).
To further study the role of L1TD1 in the proteasome
complex, we inhibited proteasome activity with MG-132,
which is known to decrease the expression of SOX2 (Vil-
chez et al., 2012). Treatment with MG-132 resulted in an
immediate reduction of L1TD1 and SOX2, but did not in-
fluence the levels of OCT4 or LIN28 at the early time points(cytoplasmic control), and PARP1 (nuclear control) in total (T),
embryoteratocarcinoma, and TCAM2 seminoma cell lines.
G, Phalloidin (actin), and secondary controls in hIPSCs (HEL 11.4).
PNA2, IgG control, and UB IP reactions. Additional detections from
ESC line HS360. Quantifications can be found in the Supplemental
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Figure 3. L1TD1 Participates in the High
Proteasome Activity of Pluripotency
(A) WB detection of PSMD11 in L1TD1, IgG
control, and UB IP reactions. hESC line
HS360.
(B) Protein expression of PSMD11 after
L1TD1 silencing. hESC line HS360. NT, non-
targeting. Quantifications can be found in
the Supplemental Results.
(C) Protein expression of L1TD1, OCT4,
LIN28, SOX2, and GAPDH after inhibition of
proteosomal activity with MG-132 inhibitor
(10 mM) versus DMSO control. hESC line H9.studied (Figure 3C). These results indicate that the protein
levels of L1TD1 correlate with proteasome activity and that
reduction of L1TD1 expression is an immediate indicator of
a decrease in hESC proteasome activity and pluripotency.
L1TD1 Is a Member of the Pluripotency Network
To understand the role of L1TD1 in regulating pluripo-
tency, we compared the L1TD1 interactome with lists of
proteins (Jadaliha et al., 2012; Van Hoof et al., 2006) and
genes (Assou et al., 2007) that are enriched in hESCs
compared with their differentiated counterparts. Based
on this analysis, 30% of the L1TD1 interaction partners
are associated with pluripotency (Figures 4A and S2A).
Nineteen of the interacting proteins had previously been
shown to be enriched in hESCs at both the gene and pro-
tein levels. Interestingly, the panel contains several factors,
such as DPPA4 (developmental pluripotency associated 4),
RFC5 (replication factor C subunit 5), and TOP2A (topo-
isomerase-IIa), whose role in the regulation of pluripotency
remains to be investigated. The interaction of L1TD1 with
TOP2A was validated (Figure S2B). In addition, silencing of
L1TD1 led to decreased TOP2A levels (Figure 1F).
L1TD1 belongs to the interactomes of Nanog (Nitzsche
et al., 2011) and Oct4 (Ding et al., 2012; van den Berg
et al., 2010) in mESCs. However, NANOG and OCT4 were
not detected as L1TD1-interacting proteins in our MS
data. It has proved to be challenging to detect these plurip-
otency factors withMS (Ding et al., 2012; Liang et al., 2008;
Pardo et al., 2010; van den Berg et al., 2010). Therefore, we
tested the presence of these proteins by immunoblotting of
the L1TD1 IPs. This approach led to the detection of OCT4,
NANOG, and SOX2 as L1TD1-interacting proteins (Fig-
ure 4B). Successful optimization of SOX2-IP further verified
L1TD1 interaction with SOX2 (Figure S2C). In addition to
these transcription factors, we demonstrated that L1TD1
interacts with the pluripotency-related proteins DNMT3B
and TRIM28 (Figure S2D). These interactions were initially
identified only in individual MS replicates. In addition,
silencing of L1TD1 led to decreased TRIM28 levels
(Figure 1F).524 Stem Cell Reports j Vol. 4 j 519–528 j March 10, 2015 j ª2015 The AuthFinally, we sought to determine which components of
the L1TD1 interactome were also present in the mESC in-
teractomes of OCT4, NANOG, and SOX2 (Figure 4C)
(Ding et al., 2012; Nitzsche et al., 2011; van den Berg
et al., 2010). We applied IPA and identified 45, 25, and 8
proteins that interact with OCT4, NANOG, and SOX2,
respectively.We then analyzed the gene expression of these
factors in human undifferentiated, early differentiated
(SSEA3), and differentiated (embryoid bodies [EBs], fibro-
blasts, and keratinocytes) cells (Figure 4D). This analysis re-
sulted in the identification of proteins that form the key
core of pluripotency at the protein level. In addition to
NANOG, L1TD1, LIN28A, SOX2, and OCT4, this analysis
suggested that MCM5 (minichromosome maintenance
complex component 5), PARP1 (poly ADP-ribose polymer-
ase 1), CDK1 (cyclin-dependent kinase 1), RFC4, and
TOP2A could have important roles in the regulation of plu-
ripotency. To evaluate the importance of these factors in
terms of pluripotency, we selected one of them to deter-
mine the influence of its silencing. Depletion of RFC4 led
to an immediate reduction of OCT4 and L1TD1 levels (Fig-
ure 4E), demonstrating that this factor is required for the
maintenance of pluripotency.
To confirm our results, we repeated selected L1TD1 pro-
tein interactions in hiPSCs (Figure S2E) and tested the spec-
ificity of the L1TD1-bead-antibody complex by performing
IP indifferentiatedHeLacontrol cells comparedwithplurip-
otent cells, including the RFC4 interaction (Figure S2F).DISCUSSION
RBPs are engaged in every aspect of RNA biology and are
essential for carrying specific RNA products from the trans-
lationmachinery to pre-mRNA splicing, transport, localiza-
tion, translation, and turnover (Glisovic et al., 2008). Our
study indicates that L1TD1 is a functional RBP in human
pluripotent cells that is associatedwith proteins that partic-
ipate in cellular RNA processes, thus shedding light on the
RNA regulation of pluripotent cells.ors
Figure 4. L1TD1 Connects Uncharacterized Factors to Core Pluripotency Regulation
(A) hESC-enriched genes (Assou et al., 2007) and proteins (Jadaliha et al., 2012; Van Hoof et al., 2006) in the L1TD1 interactome.
Overlapping hits are listed.
(B) WB detection of OCT4, SOX2, and NANOG in L1TD1, IgG control, and UB IP reactions. hESC line HS360.
(C) Proteins that interact with L1TD1 and OCT4 (n = 45), NANOG (n = 25), or SOX2 (n = 8) (Ding et al., 2012; Nitzsche et al., 2011; van den
Berg et al., 2010). The figure was constructed with the use of IPA software.
(D) RNA expression of proteins represented in Figure 4C in hESCs and differentiated cells. EB, embryoid body; DIFF.K.CYTES, differentiated
keratinocytes. Microarray data collected from previous studies (Enver et al., 2005; Golan-Mashiach et al., 2005; Skottman et al., 2005). The
figure was generated from normalized raw files using GeneSpring GX Software (Agilent Technologies Genomics). The top ten differenti-
ation-responsive genes are highlighted in yellow.
(E) Effect of RFC4 silencing (siRNA1) on the expression of L1TD1 and OCT4. hESC line HS360. Quantifications can be found in the Sup-
plemental Results.
See also Figure S2.
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Several observations support the idea that L1TD1 shuttles
between the nucleus and cytoplasm. Based on our results
and consistent with a previous report on the subcellular
proteome of hESCs (Sarkar et al., 2012), we conclude that
L1TD1 (like LIN28) can be found in cytoplasmic, nuclear,
and membrane fractions. Based on the NetNES 1.1 server,
the amino acids L811–L814 could be responsible for the nu-
clear location of L1TD1. As RBPs are known to participate in
RNA traffic through nuclear pores, it is possible that L1TD1
has a role in that process. The interaction of L1TD1 with
OCT4, SOX2, NANOG, and the nuclear pore traffic protein
karyopherin KPNA2 suggests the intriguing possibility that
L1TD1 is responsible for the nuclear import of these tran-
scription factors after their translation to protein in the
cytoplasm. Highly stem-cell-specific L1TD1 could be
responsible for thenuclear localization, thereby controlling
these transcription factors and providing an additional
checkpoint for the maintenance of pluripotency.
The network shared among L1TD1, OCT4, SOX2, and
NANOG is highly interesting. Our analysis suggests that
the nuclear epigenetic regulator PARP1 and CDK1 are key
proteins in the core pluripotency network. Recently,
PARP1 expression and PARylation activity were shown to
be increased in undifferentiated mESCs and to regulate nu-
clear reprogramming (Chiou et al., 2013; Doege et al., 2012;
Lai et al., 2012). In addition, CDK1 was shown to affect the
differentiation of mESCs through an interplay with Oct4
(Li et al., 2012). Our results also revealed a panel of proteins
that were not previously reported in the context of self-
renewal but may be involved in the regulation of pluripo-
tency. Although the role of TOP2A, RCF4, and MCM5 in
pluripotency remains uncharacterized, their contribution
to this network and function in other cell types suggest
they may have a role in regulation of the cell cycle and
DNA replication in pluripotent cells. We chose to further
investigate the role of RFC4 and demonstrated that it is
vital for maintaining pluripotency.
Post-transcriptional regulators and protein turnover
determine which factors are active in pluripotency.
Recently, the deubiquitinating enzyme Psmd14 was shown
to be essential for cellular reprogramming (Buckley et al.,
2012), andPSMD11was shownto regulate increasedprotea-
some activity in hESCs (Vilchez et al., 2012). However, it is
still unclear how proteins are selected for ubiquitination
in pluripotent cells. The presence of multiple proteasome
subunits in the highly pluripotent-specific L1TD1 interac-
tomesuggests thatL1TD1couldparticipate in this selection.
One of the central functional categories detected in the
L1TD1 interactome was splicing (Figure 1C). Cell-type-spe-
cific RBPs are able to regulate tissue-specific splicing (Licata-
losi and Darnell, 2010), which has been shown to be
unique in mESCs and reorganized during reprogramming
by RBPs U2af1 and Srsf3 (Ohta et al., 2013). The interaction526 Stem Cell Reports j Vol. 4 j 519–528 j March 10, 2015 j ª2015 The Authbetween L1TD1 (identified here in hESCs) and these two
factors implies that U2AF1 and SRSF3 also have an impor-
tant role in human pluripotency, and L1TD1 may play a
role in stem-cell-specific splicing.
In addition to regulating pluripotency, L1TD1 may have
an important function in cancer. We previously showed
that L1TD1 is expressed in selected cancer types, such as
colorectal carcinoma, ovarian germ cell tumors, and testis
seminomas and non-seminomas (Na¨rva¨ et al., 2012). Inter-
estingly, the L1TD1 interactome revealsmany proteins that
have an important role or diagnostic value in cancer. For
example, KPNA2has been shown to affectmalignant trans-
formation and its elevated expression is correlated with
poor diagnosis in multiple forms of cancer (Christiansen
and Dyrskjot, 2012).
Of all the factors in the interactome, L1TD1 has the fast-
est kinetics in response to differentiation. This implies that
L1TD1 has a regulatory role in the maintenance of plurip-
otency. Moreover, interaction with transcriptional, cell
cycle, epigenetic, proteosomal, protein traffic, and splicing
regulators further supports the regulatory role of L1TD1.
The protein interactome constructed here can be used as
an important resource for elucidating individual protein
interactions in pluripotent stem cells and possibly in
cancer stem cells. Moreover, this analysis sheds light on
post-translational regulation in pluripotency and the
importance of RBPs in pluripotent cells.EXPERIMENTAL PROCEDURES
All experiments were performed in feeder-free culture conditions
on Matrigel (BD Biosciences) in mTeSR1 media (Stem Cell
Technologies).
For IP, cells were lysed into NP-40 buffer. Lysates were preincu-
bated with 10 mg/ml RNase A (QIAGEN) at +4C. IP was carried
out using M-280 sheep anti-rabbit IgG Dynabeads (11203D;
Invitrogen) with L1TD1 HPA030064 (Ab1), HPA028501 (Ab2)
(Sigma), SOX-2 #5024 (Cell Signaling), and normal rabbit IgG
12-370 (Millipore).
IP proteins were gel separated, digested, and submitted for LC-
MS/MS analysis. The criteria used for inclusion as an L1TD1-inter-
acting protein were (1) the presence of the protein in two out of
three replicates, (2) more than one unique peptide was identified
in the L1TD1 IP analysis, and (3) on/off or R3-fold enrichment
of the identified peptides compared with the control IgG IP
reaction.
Detailed methods are described in the Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supple-
mental Experimental Procedures, two figures, and four tables and
can be found with this article online at http://dx.doi.org/10.
1016/j.stemcr.2015.01.014.ors
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